| Dale R Gregore, | |
|
501 W 14th St, Wilmington Hospital Speech Therapy Rehab, Wilmington, DE 19801-1013 | |
| (302) 428-6640 | |
| Not Available |
| Full Name | Dale R Gregore |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 501 W 14th St, Wilmington, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053749978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | O1-0000499 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dale R Gregore, 200 Hygeia Dr, Suite 2300 - Cchs Corporate Finance Center, Newark, DE 19713-2049 Ph: () - | Dale R Gregore, 501 W 14th St, Wilmington Hospital Speech Therapy Rehab, Wilmington, DE 19801-1013 Ph: (302) 428-6640 |
News Archive
Research presented at the American Academy of Pain Medicine's 26th Annual Meeting provides early published data analyzing information gathered from California's prescription monitoring program, known as the Controlled Substances Utilization Review and Evaluation System (CURES). The analysis found a two-fold increase in the likelihood of individuals receiving opioids from multiple providers or "doctor shopping" when they were also being simultaneously prescribed a single additional class of a controlled substances, such as benzodiazepines or amphetamines.
The world's most widespread test for ovarian cancer reports false-positives in 94 of 100 diagnosed cases. Now, chemists at the University of Copenhagen working with clinical researchers at University College London have developed a method able to halve the number of false-positives. When fully developed, the new test will spare a significant number of women from unnecessary worry and further testing. Furthermore, global health care providers stand to save substantial sums - just by including a test on a certain sugar molecule in tandem with the currently prevailing diagnostic test.
A team of scientists at the University of Illinois Chicago has developed a software tool that can help researchers more efficiently identify the regulators of genes. The system leverages a machine learning algorithm to predict which transcription factors are most likely to be active in individual cells.
Greatbatch, Inc., today announced results for its first quarter ended March 29, 2013 highlighted by a 19% increase in adjusted diluted EPS despite negative 4% constant currency organic revenue growth.
› Verified 6 days ago
Allyson Jane Menard, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-4200 Fax: 610-302-5618 | |
Elizabeth Golian Mccormick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Mckennans Church Rd, Wilmington, DE 19808 Phone: 302-992-5520 | |
Karen A Jarosz-iler, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 43 Weilers Bnd, Wilmington, DE 19810 Phone: 518-479-7293 | |
Ashley Underwood, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 Spruce Ave Ofc, Red Clay Consolidated School District, Wilmington, DE 19805 Phone: 302-552-3797 | |
Kathryn Mahoney, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 N Lombard St, Wilmington, DE 19801 Phone: 302-429-4102 | |
Kalisandra G Bussey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2000 Pennsylvania Ave Apt 436, Wilmington, DE 19806 Phone: 732-904-1886 | |
Nicole Rose Immediato, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5147 W Woodmill Dr Ste 21, Wilmington, DE 19808 Phone: 302-999-0702 |